| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.25 | 0.06 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |